Amyris partners with IDRI on scalable vaccine platform

By The Science Advisory Board staff writers

July 27, 2020 -- Amyris and the Infectious Disease Research Institute (IDRI) have inked a binding term sheet for the development of a planned COVID-19 RNA vaccine technology platform.

The program will utilize IRDI's expertise in infectious diseases with Amyris' fermentation platform technology to create semisynthetic squalene-based adjuvants at scale.

The IDRI is a nonprofit global health organization that works to develop solutions for infectious diseases. IDRI's vaccine platform uses a replicating RNA molecule to express viral antigens, formulated and delivered to injection sites with a nanostructured lipid carrier system that can be stockpiled for use in future epidemic situations.

The fermentation platform replaces shark-based squalene with lower-cost sugarcane-derived squalene. Amyris' squalene adjuvant has the potential to provide large quantities to meet demand for COVID-19 vaccines. The sugarcane squalene will be certified in the late stages of commercialization.

Currently, Amyris and IDRI are working informally to advance the vaccine at an accelerated timeline. The organizations anticipate the execution of a comprehensive agreement where details of the program will be formally disclosed.

Inimmune gets grant for vaccine technology
Montana-based Inimmune received a $2 million grant from the U.S. National Institute for Allergy and Infectious Diseases to develop novel adjuvant...
AGC to manufacture adjuvant for Novavax COVID-19 vaccine
AGC Biologics announced it is partnering with Novavax for large-scale good manufacturing practices production of critical components for Novavax's coronavirus...
Codiak partners with Ragon Institue for SARS-CoV-2 vaccine platform
Codiak BioSciences has entered into a strategic collaboration with the Ragon Institute of Massachusetts General Hospital, the Massachusetts Institute...
Codiak presents preclinical results for modular vaccine platform
Codiak BioSciences released new preclinical data on its engEx platform at the American Society of Gene and Cell Therapy annual meeting.

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
ESMO Virtual Congress 2020
September 14-29
Online
2020 ACCP Annual Meeting
September 20-22
Online
BioProcess International West
September 21-25
Online
BioProcess International
September 21-25
Online
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter